• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pemphigus vulgaris following second dose of mRNA-(Pfizer-BioNTech) COVID-19 vaccine.

作者信息

Agharbi Fatima-Zahra, Basri Ghita, Chiheb Soumia

机构信息

Department of Dermatology, Sheikh Khalifa Hospital, Faculty of Medicine, Mohamed VI University of Health Sciences, Casablanca, Morocco.

出版信息

Dermatol Ther. 2022 Oct;35(10):e15769. doi: 10.1111/dth.15769. Epub 2022 Sep 2.

DOI:10.1111/dth.15769
PMID:35960438
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9538658/
Abstract
摘要

相似文献

1
Pemphigus vulgaris following second dose of mRNA-(Pfizer-BioNTech) COVID-19 vaccine.第二剂mRNA（辉瑞-生物科技公司）新冠疫苗接种后发生的寻常型天疱疮
Dermatol Ther. 2022 Oct;35(10):e15769. doi: 10.1111/dth.15769. Epub 2022 Sep 2.
2
An unusual presentation of pemphigus foliaceus following COVID-19 vaccination.新型冠状病毒肺炎疫苗接种后出现的寻常型天疱疮的不寻常表现。
Australas J Dermatol. 2022 Feb;63(1):128-130. doi: 10.1111/ajd.13755. Epub 2021 Nov 24.
3
De novo severe pemphigus vulgaris following SARS-CoV-2 vaccination with BBIBP-CorV.接种BBIBP-CorV新冠疫苗后新发重症寻常型天疱疮
Dermatol Ther. 2022 Jun;35(6):e15448. doi: 10.1111/dth.15448. Epub 2022 Mar 20.
4
Commentary on 'Psoriasis flare-up associated with second dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine'.关于“第二剂辉瑞 - 生物科技公司BNT16B2b2 COVID - 19 mRNA疫苗引发银屑病”的评论
J Eur Acad Dermatol Venereol. 2022 Aug;36(8):e606. doi: 10.1111/jdv.18117. Epub 2022 Apr 22.
5
Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine.辉瑞-BioNTech mRNA新冠疫苗加强针接种后出现毛发红糠疹。
Dermatol Ther. 2022 Nov;35(11):e15791. doi: 10.1111/dth.15791. Epub 2022 Sep 7.
6
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
7
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.在报告 Janssen（强生）和 mRNA COVID-19 疫苗（辉瑞-生物科技和莫德纳）成年受种者发生不良事件后使用 COVID-19 疫苗：免疫实践咨询委员会的更新-美国，2021 年 7 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099. doi: 10.15585/mmwr.mm7032e4.
8
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.2021年3月至8月美国Moderna、辉瑞-生物科技公司和杨森（强生）疫苗在预防无免疫功能低下状况成年人新冠病毒肺炎住院方面的比较效果
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1337-1343. doi: 10.15585/mmwr.mm7038e1.
9
New-onset giant cell arteritis following COVID-19 mRNA (BioNTech/Pfizer) vaccine: a double-edged sword?新型冠状病毒肺炎信使核糖核酸（BioNTech/辉瑞）疫苗接种后新发巨细胞动脉炎：一把双刃剑？
Clin Rheumatol. 2022 May;41(5):1623-1625. doi: 10.1007/s10067-021-06041-7. Epub 2022 Feb 3.
10
Erythroderma related with the first dose of Pfizer-BioNTech BNT16B2b2 COVID-19 mRNA vaccine in a patient with psoriasis.一名银屑病患者接种第一剂辉瑞-生物科技公司BNT16B2b2 COVID-19 mRNA疫苗后出现红皮病。
Dermatol Ther. 2022 May;35(5):e15363. doi: 10.1111/dth.15363. Epub 2022 Feb 14.

引用本文的文献

1
Pemphigus and Bullous Pemphigoid Following COVID-19 Vaccination: A Systematic Review.新型冠状病毒肺炎疫苗接种后的天疱疮和大疱性类天疱疮：一项系统评价
Viruses. 2024 Dec 9;16(12):1896. doi: 10.3390/v16121896.
2
Severe aggravation and possible triggering of pemphigus vulgaris following COVID-19 vaccination: report of two cases.新型冠状病毒肺炎疫苗接种后寻常型天疱疮严重加重及可能的诱发：两例报告
An Bras Dermatol. 2024 Sep-Oct;99(5):758-762. doi: 10.1016/j.abd.2023.04.012. Epub 2024 Jun 3.
3
New Onset and Exacerbation of Autoimmune Bullous Dermatosis Following COVID-19 Vaccination: A Systematic Review.新冠疫苗接种后自身免疫性大疱性皮肤病的新发与加重：一项系统评价
Vaccines (Basel). 2024 Apr 26;12(5):465. doi: 10.3390/vaccines12050465.
4
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.COVID-19 疫苗接种对炎症性皮肤疾病和其他皮肤疾病的影响：已发表文献综述。
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
5
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.新冠疫苗接种后的皮肤反应：当前文献综述
Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022.

本文引用的文献

1
Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.新型冠状病毒疫苗接种后自身免疫性黏膜皮肤水疱病：1例寻常型天疱疮病例报告及文献综述
Pathol Res Pract. 2022 Apr;232:153834. doi: 10.1016/j.prp.2022.153834. Epub 2022 Mar 5.
2
COVID-19 vaccine BNT162b1 elicits human antibody and T1 T cell responses.COVID-19 疫苗 BNT162b1 可引发人体抗体和 T1 T 细胞应答。
Nature. 2020 Oct;586(7830):594-599. doi: 10.1038/s41586-020-2814-7. Epub 2020 Sep 30.
3
Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与人体组织之间潜在的抗原交叉反应性，可能与自身免疫性疾病增加有关。
Clin Immunol. 2020 Aug;217:108480. doi: 10.1016/j.clim.2020.108480. Epub 2020 May 24.
4
Th1/Th17-Related Cytokines and Chemokines and Their Implications in the Pathogenesis of Pemphigus Vulgaris.Th1/Th17相关细胞因子和趋化因子及其在寻常型天疱疮发病机制中的意义
Mediators Inflamm. 2017;2017:7151285. doi: 10.1155/2017/7151285. Epub 2017 Feb 22.
5
Pemphigus vulgaris following antirabies vaccination.抗狂犬病疫苗接种后发生寻常型天疱疮
J Dermatol. 2007 Oct;34(10):734-5. doi: 10.1111/j.1346-8138.2007.00373.x.
6
Pemphigus following hepatitis B vaccination--coincidence or causality?
Autoimmunity. 2005 Mar;38(2):117-9. doi: 10.1080/08916930400027078.
7
Pemphigus following tetanus and diphtheria vaccination.破伤风和白喉疫苗接种后发生的天疱疮。
Br J Dermatol. 2002 Jul;147(1):188-9. doi: 10.1046/j.1365-2133.2002.47958.x.